SciRouterVet
Open my portal

Cat · Immune · Research comparison

Best Immune Support Ingredients for Cats: What the Research Says

A research-first comparison of turkey tail PSP, L-lysine, taurine, and curcumin for feline immune support. Feline-specific evidence honestly framed; cited.

Published 2026-05-18. Last reviewed 2026-05-18. By the SciRouter team.

The feline supplement landscape is its own thing

Cats are not small dogs and are not small humans. They have meaningfully different metabolism — limited hepatic glucuronidation, obligate-carnivore amino-acid requirements (taurine, arginine), sensitivity to several phytochemicals (alliums, essential oils, some artificial sweeteners). Any cat supplement needs explicit feline-safety formulation review. The general feline-nutrition-and-immune-function picture is summarized in standard small-animal-practice references 12.

The feline immune-support supplement category is also younger and smaller than the human or canine equivalents. The feline-specific clinical research base is meaningfully thinner than the human or even canine literatures. Most of what follows uses translational logic, with the L-lysine exception (which has real feline RCT data).

A note on framing: this is informational content using structure/function language. We do not make therapeutic claims for any of these ingredients in cats. Consult your veterinarian before starting a supplement, especially if your cat has a chronic condition (CKD, hyperthyroidism, IBD) or is on prescription veterinary pharmaceuticals.

1. Turkey tail PSP — the mushroom polysaccharide

What it is. A protein-bound polysaccharide from Trametes versicolor mushroom. The deepest mushroom-polysaccharide research base in any species. The 1984 foundational PSK description 3 and 2002 mechanism review 4 anchor the human / oncology-research literature; a 2012 mouse study showed PSK augmented docetaxel response in an immunocompetent host via specifically immune-mediated mechanisms 5.

Mechanism. Pattern-recognition-receptor engagement (dectin-1 and related) on innate-immune cells, triggering cytokine release that activates downstream NK function.

Feline evidence. Thin direct RCT data in peer-reviewed indexed journals. Most published mushroom-polysaccharide feline work appears in conference proceedings rather than indexed journals. We rely on translational logic and body-weight scaling.

Dose. Body-weight-scaled from human PSP protocols for an adult cat.

Verdict. The deepest mushroom-polysaccharide mechanism story in any species. Direct feline evidence is thin; cross-species mechanism conservation is the rationale for inclusion.

2. L-lysine — the feline-specific ingredient

What it is. An essential amino acid. The feline-relevant context is feline herpesvirus-1 (FHV-1), which is endemic in domestic cats. Most cats are exposed as kittens, establish latency in trigeminal ganglia, and experience periodic reactivation under stress, immune stress, or boarding-and-travel disruption.

Mechanism. L-lysine antagonizes arginine in protein-synthesis competition; FHV-1 replication has an arginine requirement; L-lysine slows FHV-1 replication via this competition. In-vitro work demonstrated this clearly 6.

Feline evidence. The most-developed feline-clinical research base in this article. A 2002 study examined oral L-lysine for FHV-1-associated conjunctivitis in cats 7. A 2007 dietary-supplementation study evaluated cats with enzootic upper respiratory disease 8. A 2016 review of antiviral approaches for FHV-1 covered L-lysine evidence honestly, including its limits 9.

Honest framing. The mechanism is established. The clinical-effect magnitude in real-world cats is modest and context-dependent. Early enthusiasm based on in-vitro mechanism work was tempered by mixed clinical outcomes — but it remains the ingredient in this article with the most feline-specific clinical research.

Dose. Published feline supplementation studies have used 250 mg to 500 mg per cat per day.

Verdict. Most-feline-specific-evidence ingredient. Real but modest clinical effect size. Reasonable inclusion in feline immune-support stacks.

3. Taurine

What it is. An essential amino acid for cats. Cats cannot synthesize taurine adequately from cysteine or methionine precursors. Taurine deficiency causes feline dilated cardiomyopathy; foundational 1992 papers established the relationship and clinical response to supplementation 1011.

Mechanism in immune context. Taurine has broader physiological roles beyond cardiac function — including in retinal function, bile-acid conjugation, and several cellular antioxidant pathways. In immune cells specifically, taurine is involved in neutrophil oxidant-handling and lymphocyte function.

Feline evidence. Strongest evidence is for the cardiac (DCM) endpoint, not for immune endpoints directly. Modern commercial cat foods are taurine-fortified, so frank dietary deficiency is rare; supplementation in NKat is a defensive layer for cats on home-prepared, limited-ingredient, or atypical diets where taurine adequacy is not assured.

Honest framing. Taurine in NKat is feline-physiology-driven, not primary-immune-mechanism. Including it reflects the obligate-carnivore reality of cat metabolism.

Dose. Modest supplemental level consistent with feline nutrition practice.

Verdict. Feline-essential, well-tolerated, defensive insurance layer in a complete-and-balanced-diet world. Not the primary immune-mechanism ingredient.

4. Curcumin (bioavailable)

What it is. The polyphenol pigment from turmeric, in a bioavailable preparation (BCM-95). Plain dietary turmeric has very poor curcumin absorption; bioavailable preparations substantially improve human absorption per a published pilot study 12.

Mechanism. Multiple — NF-κB pathway modulation, cytokine signaling, antioxidant activity via direct ROS scavenging and Nrf2 activation. Short-hand: anti-inflammatory.

Feline evidence. Thin direct feline-RCT data for curcumin. The strongest cross-species curcumin RCT evidence is canine (joint comfort in osteoarthritis); the feline picture is less developed.

Honest framing. Inclusion of bioavailable curcumin in NKat is mechanism-driven and cross-species translational — not feline-RCT-validated.

Dose. Body-weight-scaled for an adult cat.

Verdict. Reasonable inclusion at modest doses; less feline-specific evidence than L-lysine.

5. Reishi — considered, not in primary formula

For completeness: Ganoderma lucidum (reishi) is a related polypore mushroom with a substantial immune-modulation literature 13. Turkey tail PSP already covers the mushroom-polysaccharide axis at the NKat dose; adding reishi to a cat formula at the same time as PSP risks overdosing a single mechanism axis at the expense of formula breadth.

How to think about supplement-stacking for cats

Foundational interventions first. Diet (commercial complete-and-balanced is the safe default; home-prepared diets need veterinary-nutritionist oversight), hydration support (especially for senior cats), maintained body condition score, dental care, and routine veterinary visits.

Above the foundation: NKat is the daily-baseline immune-support layer. Specific veterinary supplements (renal-support, probiotics, joint supplements for arthritic seniors) are complementary, not interchangeable with general immune support.

Bottom line

For cats specifically:

  • L-lysine has the most direct feline-clinical evidence. The mechanism is established; effect size is modest and context-dependent (notably for FHV-1 reactivation).
  • Turkey tail PSP has the deepest cross-species mechanism research base but thinner direct feline RCT data.
  • Taurine is feline-essential; supplementation is defensive insurance, especially for cats on atypical diets.
  • Bioavailable curcumin has the strongest cross-species clinical evidence in dogs (joint comfort); feline-specific evidence is thinner.

NKat combines all four. The pillar guide — Immune Support for Cats — covers each compound in more detail with full mechanism citation lists.

Frequently asked questions

Is L-lysine actually effective in cats?
The L-lysine + feline-herpesvirus-1 (FHV-1) literature is real but more nuanced than older marketing materials suggested. In-vitro work showed L-lysine inhibits FHV-1 replication via arginine antagonism [cit_maggs_2000_lysine_arginine_fhv]; clinical studies have shown mixed magnitude effects [cit_stiles_2002_lysine_fhv][cit_maggs_2007_lysine_uri]; a 2016 review covered the picture honestly [cit_thomasy_2016_fhv_antivirals]. Short answer: mechanism is established, clinical effect size is modest and context-dependent.
Are there cat-specific safety concerns with these ingredients?
Yes. Cats have limited hepatic glucuronidation (acetaminophen toxicity is the canonical example), so any cat formula needs explicit feline-safety review. NKat contains no allium-family ingredients, no xylitol, no essential oils, no compounds with feline-specific hepatic-glucuronidation concerns. Consult your veterinarian for your specific cat.
Why isn't AHCC in NKat?
AHCC has strong human immune-research data but minimal feline-specific clinical data. Cost, palatability, and the absence of cat-specific safety data factored against inclusion. Owners who want to stack AHCC with NKat can do so under veterinary guidance.
What dose of L-lysine should I give my cat?
Published feline supplementation studies have used 250 mg to 500 mg per cat per day. NKat doses L-lysine in this range as one ingredient among four. Single-ingredient lysine products typically dose 500 mg/day directly. Consult your vet for cat-specific recommendations.

References

  1. Saker KE. Nutrition and immune function. Veterinary Clinics of North America: Small Animal Practice. 2006. PMID 17085230
  2. Satyaraj E. Emerging paradigms in immunonutrition. Topics in Companion Animal Medicine. 2011. PMID 21435623
  3. Tsukagoshi S, Hashimoto Y, Fujii G, Kobayashi H, Nomoto K, Orita K. Krestin (PSK). Cancer Treatment Reviews. 1984. PMID 6238674
  4. Fisher M, Yang LX. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy. Anticancer Research. 2002. PMID 12168863
  5. Wenner CA, Martzen MR, Lu H, Verneris MR, Wang H, Slaton JW. Polysaccharide-K augments docetaxel-induced tumor suppression and antitumor immune response in an immunocompetent murine model. International Journal of Oncology. 2012. PMID 22159900
  6. Maggs DJ, Collins BK, Thorne JG, Nasisse MP. Effects of L-lysine and L-arginine on in vitro replication of feline herpesvirus type-1. American Journal of Veterinary Research. 2000. PMID 11131583
  7. Stiles J, Townsend WM, Rogers QR, Krohne SG. Effect of oral administration of L-lysine on conjunctivitis caused by feline herpesvirus in cats. American Journal of Veterinary Research. 2002. PMID 16206789
  8. Maggs DJ, Sykes JE, Clarke HE, Yoo SH, Kass PH, Lappin MR, Rogers QR, Waldron MK, Fascetti AJ. Effects of dietary lysine supplementation in cats with enzootic upper respiratory disease. Journal of Feline Medicine and Surgery. 2007. PMID 17055313
  9. Thomasy SM, Maggs DJ. A review of antiviral drugs and other compounds with activity against feline herpesvirus type 1. Veterinary Ophthalmology. 2016. PMID 27091747
  10. Pion PD, Kittleson MD, Skiles ML, Rogers QR, Morris JG. Dilated cardiomyopathy associated with taurine deficiency in the domestic cat: relationship to diet and myocardial taurine content. Advances in Experimental Medicine and Biology. 1992. PMID 1387282
  11. Pion PD, Kittleson MD, Thomas WP, Delellis LA, Rogers QR. Response of cats with dilated cardiomyopathy to taurine supplementation. Journal of the American Veterinary Medical Association. 1992. PMID 1500324
  12. Antony B, Merina B, Iyer VS, Judy N, Lennertz K, Joyal S. A Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM-95CG (Biocurcumax), A Novel Bioenhanced Preparation of Curcumin. Indian Journal of Pharmaceutical Sciences. 2008. PMID 20046768
  13. Wang X, Lin Z. Immunomodulating Effect of Ganoderma (Lingzhi) and Possible Mechanism. Advances in Experimental Medicine and Biology. 2019. PMID 31777013

NKat

The SciRouter NKat formula is built around the compounds discussed in this article. Join the waitlist for early access.

See NKat →